Invention Grant
- Patent Title: Agents that modulate immune cell activation and methods of use thereof
-
Application No.: US16572142Application Date: 2019-09-16
-
Publication No.: US11359020B2Publication Date: 2022-06-14
- Inventor: Gordon J. Freeman , Arlene H. Sharpe , Yanping Xiao , Loise Francisco , Rosemarie Dekruyff , Dale Umetsu
- Applicant: Dana-Farber Cancer Institute, Inc. , Children's Medical Center Corporation , President and Fellows of Harvard College
- Applicant Address: US MA Boston; US MA Boston; US MA Cambridge
- Assignee: Dana-Farber Cancer Institute, Inc.,Children's Medical Center Corporation,President and Fellows of Harvard College
- Current Assignee: Dana-Farber Cancer Institute, Inc.,Children's Medical Center Corporation,President and Fellows of Harvard College
- Current Assignee Address: US MA Boston; US MA Boston; US MA Cambridge
- Agency: Foley Hoag LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; G01N33/50 ; A61K39/395 ; A61K45/06 ; C07K14/705 ; G01N33/68
Abstract:
The present invention relates to compositions and methods for the immunomodulation mediated by the interaction of PD-L2 and RGMb.
Public/Granted literature
- US20200095325A1 AGENTS THAT MODULATE IMMUNE CELL ACTIVATION AND METHODS OF USE THEREOF Public/Granted day:2020-03-26
Information query
